Bioter S.A. (ATH:BIOT)
Greece · Delayed Price · Currency is EUR 0.2060
0.00 (0.00%)
At close: May 30, 2025
Bioter Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.43 | 0.39 | 1.26 | 0.5 | 0.25 | 0.25 | |
Revenue Growth | -66.32% | -69.00% | 151.50% | 98.02% | 2.44% | 7.90% |
Cost of Revenue | 0.26 | 0.23 | 0.3 | 0.55 | 0.27 | 1.18 |
Gross Profit | 0.16 | 0.16 | 0.96 | -0.05 | -0.02 | -0.94 |
Selling, General & Admin | 11.41 | 2.03 | 12.95 | 2.43 | 1.42 | 0.51 |
Other Operating Expenses | 55.25 | - | - | - | - | - |
Operating Expenses | 66.66 | 2.03 | 12.95 | 2.43 | 1.42 | 0.51 |
Operating Income | -66.5 | -1.88 | -11.99 | -2.48 | -1.43 | -1.44 |
Interest Expense | -0.06 | -0.03 | -10.96 | -10.18 | -9.53 | -8.59 |
Interest & Investment Income | - | - | 0.04 | - | 0.01 | 0.35 |
Earnings From Equity Investments | 0.16 | 0.16 | 0.12 | - | - | 0.08 |
Other Non Operating Income (Expenses) | 0.11 | 0.03 | 0.03 | 0.02 | 0.03 | 0.38 |
EBT Excluding Unusual Items | -66.29 | -1.71 | -22.77 | -12.63 | -10.92 | -9.22 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.69 |
Gain (Loss) on Sale of Assets | - | - | - | 0.35 | - | - |
Asset Writedown | - | - | 0.34 | 0.25 | 0.76 | 0.77 |
Legal Settlements | - | - | 0.15 | - | - | - |
Other Unusual Items | 55.99 | 55.99 | 0.13 | - | 0.71 | 0.33 |
Pretax Income | -10.3 | 54.28 | -22.15 | -12.03 | -9.45 | -8.8 |
Income Tax Expense | -1.14 | -0.16 | -1.02 | -0.26 | 0.21 | 0.02 |
Earnings From Continuing Operations | -9.15 | 54.44 | -21.13 | -11.78 | -9.66 | -8.82 |
Minority Interest in Earnings | -0 | 0.06 | -0.13 | 0.1 | -0.01 | 0.01 |
Net Income | -9.16 | 54.49 | -21.26 | -11.68 | -9.68 | -8.81 |
Net Income to Common | -9.16 | 54.49 | -21.26 | -11.68 | -9.68 | -8.81 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 16 | 17 | 17 | 17 | 17 | 17 |
Shares Outstanding (Diluted) | 16 | 17 | 17 | 17 | 17 | 17 |
Shares Change | -2.56% | - | - | - | - | - |
EPS (Basic) | -0.56 | 3.26 | -1.27 | -0.70 | -0.58 | -0.53 |
EPS (Diluted) | -0.56 | 3.26 | -1.27 | -0.70 | -0.58 | -0.53 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.57 | 55.49 | -12.05 | -5.79 | -9.46 | -6.43 |
Free Cash Flow Per Share | 0.04 | 3.32 | -0.72 | -0.35 | -0.56 | -0.38 |
Gross Margin | 38.12% | 39.85% | 76.33% | -9.62% | -5.95% | - |
Operating Margin | -15647.29% | -482.00% | -955.70% | -495.99% | -569.05% | -585.37% |
Profit Margin | -2154.12% | 14008.48% | -1693.87% | -2340.88% | -3840.08% | -3580.89% |
Free Cash Flow Margin | 135.06% | 14265.30% | -960.32% | -1160.92% | -3753.18% | -2612.19% |
EBITDA | -66.39 | -1.77 | -11.9 | -2.38 | -1.34 | -1.32 |
D&A For EBITDA | 0.11 | 0.1 | 0.09 | 0.09 | 0.09 | 0.12 |
EBIT | -66.5 | -1.88 | -11.99 | -2.48 | -1.43 | -1.44 |